Recombinant Human NR4A2 Protein (Yeast)，His

NR4A2, also known as Nuclear Receptor Subfamily 4 Group A Member 2, is a transcription factor that belongs to the nuclear receptor family, playing a pivotal role in various biological processes, including neurodevelopment, metabolism, and immune response. Research has increasingly focused on NR4A2 due to its involvement in neurodegenerative diseases, particularly Parkinson's disease, where its expression is altered and linked to neuronal survival and apoptosis. Furthermore, NR4A2 is implicated in the regulation of several genes related to inflammation and oxidative stress, making it a potential target for therapeutic interventions. As a result, the study of NR4A2 recombinant proteins has garnered significant interest, as these proteins can be utilized to elucidate its mechanisms of action, interactions with other cellular components, and regulatory pathways. Understanding NR4A2 function at a molecular level may lead to the development of novel treatments aimed at restoring its activity or mitigating its dysregulation in disease states. The use of recombinant NR4A2 also facilitates high-throughput screening of small molecules that could modulate its activity, opening avenues for drug discovery and contributing to the growing field of targeted therapy in neurodegenerative and inflammatory diseases.